Gottlieb: 'End the Shenanigans' on Delaying Generic Drug Competition
By Zachary Brennan -
Published 08 November 2017
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb on Wednesday called to "end the shenanigans" that often delay or restrict generic drug competition.
Categories: News, US, FDA, FTC, Generic drugs, Government affairs, Reimbursement
Tags: generic drug competition, REMS, shared REMS, pay-for-delay